πŸ‡ΊπŸ‡Έ FDA
Patent

US 7041789

RFRP-3 and DNA thereof

expired A61KA61K38/00

Quick answer

US patent 7041789 (RFRP-3 and DNA thereof) held by Takeda Pharmaceutical Company Limited expires Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 09 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/00